Prognostic significance of replication protein A (RPA) expression levels in bladder urothelial carcinoma

BJU International

Volumn 108, Issue 2 B, 2011, Pages

  Levidou, Georgia ^a   Gakiopoulou, Hariklia ^a   Kavantzas, Nikolaos ^a   Saetta, Angelica A ^a   Karlou, Maria ^a   Pavlopoulos, Petros ^b   Thymara, Irene ^a   Diamantopoulou, Kalliopi ^a   Patsouris, Efstratios ^a   Korkolopoulou, Penelope ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b First Social Security Hospital   (Greece)

Author keywords

bladder urothelial carcinoma; immunoexpression; RPA

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN D1; REPLICATION FACTOR A; REPLICATION FACTOR A1; REPLICATION FACTOR A2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; SOLID TUMOR; SURVIVAL TIME; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CYCLIN D1; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; REPLICATION PROTEIN A; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 79960084937     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09828.x     Document Type: Article

References (23)

1. Nowell PC,. Mechanisms of tumor progression. Cancer Res 1986; 46: 2203-7 (Pubitemid 16120666)
2. Bochkarev A, Pfuetzner RA, Edwards AM, Frappier L,. Structure of the single-stranded DNA-binding domain of replication protein A bound to DNA. Nature 1997; 385: 176-81 (Pubitemid 27034221)
3. Bochkarev A, Bochkareva E,. From RPA to BRCA2: lessons from single-stranded DNA binding by the OB-fold. Curr Opin Struct Biol 2004; 14: 36-42 (Pubitemid 38249590)
4. Zou Y, Liu Y, Wu X, Shell SM,. Functions of human replication protein A (RPA): from DNA replication to DNA damage and stress responses. J Cell Physiol 2006; 208: 267-73 (Pubitemid 43993416)
5. Kim C, Wold MS,. Recombinant human replication protein A binds to polynucleotides with low cooperativity. Biochemistry 1995; 34: 2058-64
6. Ward IM, Minn K, Chen J,. UV-induced ataxia-telangiectasia-mutated and Rad3-related (ATR) activation requires replication stress. J Biol Chem 2004; 279: 9677-80 (Pubitemid 38372562)
7. He Z, Henricksen LA, Wold MS, Ingles CJ,. RPA involvement in the damage-recognition and incision steps of nucleotide excision repair. Nature 1995; 374: 566-9
8. Li L, Lu X, Peterson CA, Legerski RJ,. An interaction between the DNA repair factor XPA and replication protein A appears essential for nucleotide excision repair. Mol Cell Biol 1995; 15: 5396-402
9. Singh KK, Samson L,. Replication protein A binds to regulatory elements in yeast DNA repair and DNA metabolism genes. Proc Natl Acad Sci USA 1995; 92: 4907-11
10. de Laat WL, Jaspers NG, Hoeijmakers JH,. Molecular mechanism of nucleotide excision repair. Genes Dev 1999; 13: 768-85 (Pubitemid 29169836)
11. Iftode C, Daniely Y, Borowiec JA,. Replication protein A (RPA): the eukaryotic SSB. Crit Rev Biochem. Crit Rev Biochem Mol Biol 1999; 34: 141-80 (Pubitemid 29326003)
12. He Z, Brinton BT, Greenblatt J, Hassell JA, Ingles CJ,. The transactivator proteins VP16 and GAL4 bind replication factor A. Cell 1993; 73: 1223-32 (Pubitemid 23180495)
13. ) 32,000 Subunit of replication protein A in breast cancer. Clin Cancer Res 2002; 8: 752-8 (Pubitemid 34742104)
14. Fernández-Madrid F, Tomkiel JE,. Antinuclear antibodies as potential markers in the diagnosis and prognosis of lung cancer. In, Shoenfeld Y, Gershwin ME, eds. Cancer and Autoimmunity, Amsterdam: Elsevier Science, 2000: 151-8
15. Givalos N, Gakiopoulou H, Skliri M, et al,. Replication protein A is an independent prognostic indicator with potential therapeutic implications in colon cancer. Mod Pathol 2007; 20: 159-66 (Pubitemid 46422169)
16. Peters KB, Wang H, Brown JM, Iliakis G,. Inhibition of DNA replication by tirazapamine. Cancer Res 2001; 61: 5425-31
17. Eble JN, Epstein JI, Seternhenn IA,. World Health Organization Classification of Tumours. Pathology and Genetics, Tumours of the Urinary System and Male Genital Track. Lyon: IARC Press, 2004: 89-115
18. Mikulowski P, Hellsten S,. T1G1 urinary bladder carcinoma: fact or fiction? Scand J Urol Nephrol 2005; 39: 135-7 (Pubitemid 40632328)
19. Levidou G, Saetta AA, Karlou M, et al,. d-type cyclins in superficial and muscle-invasive bladder urothelial carcinoma: correlation with clinicopathological data and prognostic significance. J Cancer Res Clin Oncol 2010; 136: 1563-71
20. Treuner K, Eckerich C, Knippers R,. Chromatin association of replication protein A. J Biol Chem 1998; 273: 31744-50 (Pubitemid 29177105)
21. Proctor AJ, Coombs JM, Cairns JP, Knowles MA,. Amplification at chromosome 11q13 in transitional cell tumours of the bladder. Oncogene 1991; 6: 789-95 (Pubitemid 21924152)
22. Korkolopoulou P, Konstantinidou AE, Thomas-Tsagli E, Christodoulou P, Kapralos P, Davaris P,. WAF1/p21 protein expression is an independent prognostic indicator in superficial and invasive bladder cancer. Appl Immunohistochem Mol Morphol 2000; 8: 285-92
23. Pryor JP,. Factors influencing the survival of patients with transitional cell tumours of the urinary bladder. Br J Urol 1973; 45: 586-92